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V.A.C. instillation: in vitro model. Part 2
V.A.C. Instillation: ein in vitro Modell. Teil 2
Ludwig Labler* and Otmar Trentz
Division of Trauma Surgery, Department of Surgery,
University Hospital Zurich, Zurich, Switzerland
Abstract
The behavior of a liquid in foam in the course of the
V.A.C. instillation was investigated in an in vitro model
by visualization using an aqueous color solution and by
a quantitative determination of changing concentration of
Ringerlactate solution.
Keywords: infected wound; V.A.C.; V.A.C. instillation;
vacuum assisted closure.
Zusammenfassung
Das Verhalten einer Flu¨ssigkeit im Schaumstoff wa¨hrend
der V.A.C. Instillation wurde in einem in vitro Modell
untersucht, visuell mit einer wa¨ssrigen Farbstofflo¨sung
und durch quantitative Bestimmung der sich a¨ndernden
Konzentration der Ringerlactat-Lo¨sung.
Schlu¨sselwo¨rter: V.A.C.; V.A.C. Instillation; Vakuumver-
siegelung; Wundinfektion.
Introduction
In Part 1 of our study w2x, we presented an in vitro
V.A.C. instillation model and investigated the instillation
volume in dependence of time interval as well as the
reproducibility of the system in general. As each instilla-
tion step leaves a part of the fluid, the residual volume,
behind in the foam, the foam content is not completely
removed and cannot be replaced by the next fluid portion
in a single step w1, 2x. Instead, a supposedly rather com-
plicated multi-step process has to be anticipated. In this
study we used the above model and investigated the
manner of fluid movements in the foam during instillation
and V.A.C. phases by observation of a colored solution
and by quantitative estimation of Cl- concentrations of
Ringerlactate solution in the course of a stepwise dilution
with water.
*Corresponding author: Ludwig Labler MD,
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Ra¨mistrasse 100, 8091 Zurich, Switzerland
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Materials and methods
V.A.C. instillation in vitro model
All experiments in this study were performed with the
model described in Part 1 w2x using a medium size foam
(V.A.C. Medium Dressing Assembly, 18=12.4=3.3 cm,
Kinetic Concepts Inc., San Antonio, TX, USA. cf. Part 1,
figure 1a).
Fluid movement in the foam during instillation
The model as under 1. Non-glare glass sheet was used
as foam support this time. The iv bottle was filled with a
color solution (COLODUR Aqua-Buntlack Seidenmatt,
weiss, J.W. Ostendorf, Zug, Switzerland, 50 ml were
made up to 2000 ml with distilled water). The soft filter
in the drip chamber of the infusion set was perforated to
enable the colloid color solution to pass. The experi-
ments were carried out with the foam on the glass sheet
either in a horizontal or in a vertical position. When in
vertical position, the two TRAC PADs were put on the
foam either horizontally side by side, or vertically one
upon another. The infusion tubing was then connected
with the upper or with the lower PAD (center-to-center
distance of the PADs was always 6 cm). Each experiment
was performed with new foam. The infusion sets with
perforated filters were used repeatedly. The foam was
evacuated, the infusion tubing clamp opened and about
100 ml of the color solution (iv bottle scale) were let into
the foam (instillation). The infusion tubing clamp was
closed and a picture of the foam was taken through the
glass sheet. The container clamp was then opened and
the foam content transferred to the container (V.A.C.
phase). The process was repeated until the container
tubing was free of bubbles. Such a ‘‘stabilized’’ system
was used for further experiments.
Replacement of fluids in the foam (simulation of
subsequent instillations)
Color solution replaced by distilled water The iv bot-
tle of the above described ‘‘stabilized’’ system was
replaced by one filled with distilled water and equipped
with a new infusion set (with intact filter). Instillations of
100 ml were followed by V.A.C. phases as long as most
of the color was replaced by water. Pictures were taken
after each instillation.
Ringerlactate solution replaced by distilled water A
‘‘stabilized’’ system in horizontal position as under 1, iv
bottle filled with Ringerlactate solution (Ringerlactate B.
Braun, B. Braun Medical AG, Emmenbru¨cke, Switzer-
land). The iv bottle and the infusion set were discon-
nected and replaced by an iv bottle filled with distilled
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Figure 1 V.A.C. instillation model with catheters.
Catheters 1–4 are positioned 0.5 cm above the foam bottom,
catheters 5–8 0.5 cm below the foam top.
Figure 2 Foam in horizontal position.
Instillation with color solution. a–c: 1st Instillation, top and lateral view, view from below; d–g: 2nd–5th instillation, top view.
water. The infusion set was replaced by a new one. The
tare weight of both the bottle and the container was esti-
mated. The instillation intervals were varied (range
20–90 s) under constant hold periods (60 s). Each instil-
lation interval included ten instillations. The weight of
inlets and outlets was estimated and expressed in milli-
liters. The infusion set and the screw cup were replaced
by new ones when the iv bottle was refilled. The outlets
were collected and finally the sponge squeezed to get a
sample of the residual volume. The Cl- concentration in
the outlets and in the residual volume was estimated vol-
umetrically in 5 ml samples. A theoretical course of the
dilution was calculated using the mean outlet volume
(ml), the mean residual volume of 78 ml determined for
the medium size foam (cf. Part 1) and by means of the
formula
c sresidual volume/(residual volumeqoutlet)qn 1
= c (csconcentration in % Ringerlactate;n
starting c s100%) (1)1
Fluid movement in different foam locations The sys-
tem as described above, except that eight iv catheters
(Insyte 14 GA, Vialon, Spain or Delta Ven 2, Delta Med
s.r.l., Viadana, Italy) were introduced into dry foam. Four
catheters were positioned 0.5 cm above the foam bottom
(nos 1–4) and the remaining ones (nos 5–8) 0.5 cm below
its top (Figure 1). The points of the needles of each group
of four catheters were side by side on the same level.
The catheters were sealed tightly with an adhesive drape
(OpSite Flexigrid, SmithqNephew Medical Limited, Hull,
England). Each catheter was equipped with a 20 cm tub-
ing (G-Set, Galpro srl, Alessandria, Italy) and a stopcock
(Discofix C, B Braun, Melsungen AG, Melsungen, Ger-
many). Finally, the system was stabilized by instillation
with Ringerlactate solution as described above using
approximately 100 ml inlets. The bottle and infusion set
were disconnected and substituted by an iv bottle filled
with distilled water. The aqueous inlets of 90 s were fol-
lowed by a V.A.C. phase. After each instillation, sam-
ples were taken from the eight catheters by a 10 ml
syringe. At first, 4 ml were withdrawn and discarded. A
5 ml sample was then collected for analysis. The Cl- con-
centration was estimated volumetrically in 3 ml samples.
Volumetric Cl- determination in Ringerlactate
solution
The sample was diluted with distilled water. The Cl- con-
tent, declared as 112.2 mmol/l in Ringerlactate B. Braun,
was determined according to Mohr w3x by titration with
N/20 AgNO3 and sodium chromate solution as indicator.
The estimated Cl- concentration was expressed in % of
Ringerlactate concentration (cs100%).
Results
The mode of filling the foam with the color solution is
shown in Figures 2 and 3. In horizontal position, the bot-
tom area of the foam is filled with the fluid at once, leav-
ing the upper part empty (Figure 2a–c, top and lateral
view and view from below). Next instillations successively
filled the upper room (Figure 2d–g). Figure 3 shows the
foam in vertical position and different TRAC PADs
arrangements and its stepwise filling with the color
solution.
The manner of the fluid movement in the foam in the
course of subsequent instillations was the next object of
our study. The replacement of the foam content, removed
during the V.A.C. phase, by another fluid portion (both
being of the same composition in reality) was simulated
in our model by two fluids distinguishable either by their
physical or chemical nature. A ‘‘stabilized’’ system, i.e., a
system where the air was almost completely removed
from the foam, was used in all experiments. A replace-
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Figure 3 Foam in vertical position.
Instillation with a color solution. a: TRAC PADs horizontal. aa: front view; ab–ae: 1st–4th instillation, view from behind. b: TRAC
PADs vertical, inlet above. ba: front view; bb–bg: 1st–6th instillation, view from behind. c: TRAC PADs vertical, inlet below. ca: front
view; cb–ce: 1st–4th instillation, view from behind.
Figure 4 Foam in horizontal position.
Replacement of color solution by distilled water. a: Initial stage, stabilized system, view from below. b–f: 1st–5th instillation, view from
below. g–k: 1st–5th V.A.C. phase, view from below.
ment of a color solution by distilled water was chosen
for a visual observation of the dilution process. The
results of experiments carried out with foam both in hor-
izontal and vertical position together with different
TRAC PAD arrangements are illustrated in Figures 4
and 5. The dark coloration shows the distilled water por-
tions delivered during instillations.
As the Cl- concentration in Ringerlactate solution is
easily estimated volumetrically w3x, we chose a replace-
ment of the former by distilled water for quantitative
determination of its stepwise dilution in the outlets. As
well as in the experiments described above, a ‘‘stabi-
lized’’ system was used, filled with a Ringerlactate solu-
tion this time. The instillation phase time interval in
particular measurements was 20, 40, 60 and 90 s. The
data of the decreasing Cl- concentrations obtained from
the outlets are summarized in Table 1. A graphical com-
parison of experimental and calculated dilution is shown
in Figure 6. The foams before having been discarded
were squeezed to get a sample of the residual volume
which was analyzed as well (Table 1 and Figure 7).
The Cl- concentrations in different foam locations were
determined in a device (Figure 1) which allowed collect-
ing analytical samples directly from the foam after each
instillation. Analytical data obtained are summarized in
Table 2. A schematic cross section of the foam after sev-
en instillations (Figure 8) provides a view of the concen-
tration pattern in the foam. The Cl- concentrations in the
scheme are indicated both by numerals and by color gra-
dation (100% Ringer solutionsblack, pure distilled
waterscolorless).
Discussion
The V.A.C. instillation, the recent modification of the
negative pressure therapy, has proven to be a useful
technique in the clinical practice for the treatment of
infected and problematic wounds. Notwithstanding, what
happens in the foam in general and the manner in which
the fluid behaves in the course of the instillation phases
has remained prevailingly unknown.
We were interested in the first place in the foam filling
process and in the behavior of the fluid during subse-
quent instillations. Before the first instillation, a certain air
volume is still present in the evacuated dry and collapsed
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Figure 5 Foam in vertical position.
Replacement of color solution by distilled water. a: TRAC PADs horizontal. aa: Initial stage, stabilized system, view from behind;
ab–af: 1st–5th instillation, view from behind; ag–ak: 1st–5th V.A.C. phase, view from behind. b: TRAC PADs vertical, inlet above.
ba: Initial stage, stabilized system, view from behind; bb–bd: 1st–3rd instillation, view from behind; be–bg: 1st–3rd V.A.C. phase, view
from behind. c: TRAC PADs vertical, inlet below. ca: Initial stage, stabilized system, view from behind; cb–ce: 1st–4th instillation,
view from behind; cf–ci: 1st–4th V.A.C. phase, view from behind.
foam. To fill the foam more or less completely with the
fluid, several instillations and V.A.C. phases are needed
before the bubbles are removed from the container tub-
ing w2x. To visualize the process of the foam filling a dilut-
ed aqueous white color solution was used. The fluid
completely fills the whole bottom area of the horizontally
positioned foam already during its first delivery into the
collapsed dry foam (Figure 2b,c). The upper part of the
foam remains empty (Figure 2a) and fills stepwise in the
course of the following instillations (Figure 2d–g). Nev-
ertheless, even after five liquid deliveries, small, discon-
nected empty areas are still visible by darker coloration
(Figure 2g). The foam in clinical practice serves as a
drug-release system and only the parts of the foam con-
tacting the wound, i.e., the bottom surface and the sides,
are pertinent for the physiological action. In view of Fig-
ure 2, the system seems to be in full action already after
the first solution delivery at least as concerns the bottom
area. The extent of participation of the sides on the drug
release in only partly filled foam is difficult to define. The
literature recommends fixing the V.A.C. instillation sys-
tem w4x always in a horizontal position. The customary
V.A.C. therapy, however, has been applied to cover
wounds in all possible body locations. It was of interest
how, if at all, the system worked in a vertical position.
Figure 3 shows the results obtained with all three pos-
sible positions of the PADs. The foams were filled
upwards as anticipated, regardless of the position of the
delivery tubing, and an entirely fully active area was not
achieved before several instillations, their number
depending on the PADs’ arrangement. Anyhow, the ver-
tical arrangement, as we see it, when repeated prelimi-
nary instillations were accepted, might be worth trying in
the practice.
The above experiments merely show how the foam fills
irrespective of the liquid behavior in the course of sub-
sequent instillations. The process proceeds in fact be-
tween a new delivery and the remainder in the foam, the
residual volume. The residual volume, remaining in the
evacuated foam and amounting to 78 ml on average for
the foam of medium size w2x, is in no way negligible. Con-
sequently, the instillation is not a single and simple
replacement of solutions as assumed w1x but a suppos-
edly complicated multi-step dilution process. In our mod-
el experiment, we had to distinguish between the fluid in
the foam and the replacing liquid. For this purpose and
to eliminate the irregularities during the first few instilla-
tions, we used a ‘‘stabilized’’ system filled with the col-
ored solution as described above and the instillations
that followed were then performed with distilled water.
The experiment was started with the foam in horizontal
position (Figure 4). The visualization of the process is nat-
urally limited to the bottom area only. There is always a
dark water area, shifted towards the delivery PAD, and
its white surrounding of the color solution which does not
disappear even after several instillations. Both areas are
separated by a narrow gray ring of a mixture of both
phases indicating a very limited diffusion of the liquid
phases in the foam. It should not be forgotten that in
reality the foam bottom is opened towards the wound
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Figure 6 Replacement of Ringerlactate solution by distilled water: experimental and calculated course.
Foam horizontal, instillation phase variable, stabilized system, initial stage: Ringerlactate solutions100%. a: Instillation phase 20 s.
b: Instillation phase 40 s. c: Instillation phase 60 s. d: Instillation phase 90 s.
Figure 7 Replacement of Ringerlactate solution by distilled
water: concentration in residual volume.
See Figure 6, % of Ringerlactate. Experimental: a: 20 s; c: 40 s;
e: 60 s; g: 90 s. Calculated: b: 20 s; d: 40 s; f: 60 s; h: 90 s.
surface, which is not realizable in the model. Whereas
the model system comes to a standstill after removal of
the foam content during the V.A.C. phase, in the wound
an undefined quantity of the wound secret is sucked in
and removed and the fluid in the foam is in constant
movement. The residual volume, which comes in contact
with the next instillation, then consists supposedly most-
ly of the wound secret. Thus, the photographs of the
V.A.C. phases, shown in Figure 4g–k, should be inter-
preted carefully. The instillation process in vertically posi-
tioned foams mostly proceeds in a similar manner (Figure
5). The pictures of the V.A.C. phases contain, besides
the dark water and white color area, larger gray areas in
upper foam parts (Figure 5ag–ak, be–bg, cf–ci). We take
them for empty pockets left behind after the fluid was
shifted down by their own weight. In the corresponding
pictures of the foam in horizontal position, this phenom-
enon is absent because it takes place supposedly in the
upper part of the foam.
For a quantitative determination of the dilution process
we used Ringerlactate solution and distilled water. As
described above, the system in horizontal position was
stabilized beforehand with a Ringerlactate solution. Ten
instillations with distilled water were carried out in four
different time intervals. In order to maintain standard con-
ditions, a constant hold phase interval of 60 s was put
in between instillation and V.A.C. phases. The decrease
of the Cl- concentration was estimated in the outlets and
compared with the calculated values (Table 1 and Figure
6). The experimental course and the deviations from the
calculated course are similar in all four measurements,
indicating a limited diffusion of the liquid and its non-
uniform distribution in the foam. This applies, above all,
to the first outlet with a concentration in part markedly
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Figure 8 Replacement of Ringer solution by distilled water. Concentrations in foam locations. (Schematic longitudinal foam cross
section.)
higher than calculated. It seems that the remote foam
content is pushed more or less undiluted forward into the
container. The concentrations of the following outlets and
their alternation towards the calculated values are less
clear and we do not have a satisfactory answer for it.
The same applies to the surprisingly high Cl- concentra-
tions, proportionally reversed to the instillation volume, of
the residual volumina obtained from squeezed foams
(Table 1 and Figure 7).
An approximate view of what goes on inside the foam
gave the experiment shown in Figure 1. By means of
eight catheters introduced into different parts of the
foam, samples were collected after each instillation and
their Cl- concentrations estimated (Table 2). A schematic
cross section of the foam (Figure 8) illustrates the irreg-
ular distribution of the concentrations. The top cross sec-
tion (first inlet) shows the shift of higher concentrations
in direction of the outlet PAD in agreement with the
observation discussed above. Although the concentra-
tions in the particular sectors of the foam differ substan-
tially, their mean value agrees remarkably well with the
calculated data (Table 2).
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Table 2 Replacement of Ringerlactate solution by distilled water. Concentrations in different foam locations.
Outlet no Inlet Catheter no and concentration (%) Concentration of
(ml water) 8 7 6 5 Ringerlactate solution in
foam
4 3 2 1 Mean Calculated1
1 140 70.4 49.3 18.3 28.2
73.2 26.8 1.4 14.1 35.2 35.8
2 139 38.0 11.3 1.4 5.6
40.8 2.8 1.4 2.8 13.0 12.9
3 138 15.5 1.4 0.0 3.5
14.1 0.0 0.0 0.0 4.3 4.7
4 130 5.6 0.0 0.0 3.5
4.9 0.0 0.0 0.0 1.8 1.8
5 124 5.6 0.0 0.0 2.1
3.5 0.0 0.0 0.0 1.4 0.7
6 124 1.4 0.0 0.0 1.4
0.0 0.0 0.0 0.0 0.4 0.3
7 126 2.1 0.0 0.0 0.0
1.0 0.0 0.0 0.0 0.4 0.1
Mean residual volumes78 ml w2x, samples for analysis: 3 ml. 1 Calculated concentration: cnq1scn * 78/(78qinlet).
In conclusion, as demonstrated in the model, V.A.C.
instillation is a rather complicated process. An important
additional circumstance which has to be taken into con-
sideration is the residual volume probably consisting
mostly of a wound secret which then dilutes and mixes
in some way with the physiological solution in the foam
during instillations. Because of its not negligible amount,
a reasonable instillation volume is necessary. Instillation
intervals carried out under conditions as described in our
study should, in our opinion, amount to between 60 and
120 s. Shorter instillations were of little use being too
small in relation to the residual volume. Instillations over
two minutes are also not justified, because the foam pro-
duces a pressure on the covering sheet and simultane-
ously the liquid starts to get out of the foam and works
its way under the transparent adhering sheet. Last but
not least it seems that the technique might be of use also
in other positions than the horizontal one.
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